Vital Edge
A data-driven, evidence-based hemostasis optimization program
The Burden of Bleeding
30%
Average rate of bleeding complications during surgery1
10 Days
Length of stay associated with bleeding-related complications or transfusions1
$10K+
Potential incremental cost of bleeding complications per patient hospitalization for major surgeries1
The Challenge of Surgical Bleeding
Surgical bleeding can lead to complications and increased allogeneic blood utilization creating headwinds to meeting your performance measures.
Surgical bleeds are associated with increased complication rates in1:
● Surgical revisions
● Transfusions
● Length of stay
● Increased resource utilization
Increasing focus on blood management protocols emphasizing intraoperative interventions, including use of topical hemostatic agents, can help mitigate these challenges.
What Is Vital Edge?
Vital Edge is a data-driven, evidence-based hemostasis optimization program. It supports hospital initiatives aimed at:
● Reducing intraoperative blood loss
● Reducing blood transfusions
● Optimizing outcomes after surgery
● Reducing waste
● Cost avoidance
It provides a non-commercial approach to partnering with hospitals in support of their goals and quality initiatives.
Efficiencies in the Operating Room
Through Vital Edge, Baxter’s Advanced Surgery team partners with hospitals in support of their goals and quality programs. Vital Edge provides actionable insights and practical solutions related to intraoperative hemostasis that will help healthcare providers realize marked improvements in three, interconnected areas of surgical care:
● Clinical efficacy
● Financial performance
● Operational efficiency
Vital Edge offers several potential collaboration opportunities
Live Utilization Review
To help hospitals assess their current state of hemostat utilization, Baxter Medical Affairs conducts unbiased observation reviews of hemostat and sealant use, resulting in a detailed report of findings and improvement opportunities
Health Economic Assessment
To help hospitals quantify potential economic cost savings, Baxter Market Access works with hospitals to create a model to assess potential savings and measure results after implementing improvement opportunities
Patient Blood Management
To help hospitals assess the impact of implementing an intraoperative hemostasis protocol to reduce transfusions, Baxter Market Access supports operating room and blood bank staff in identifying clinical endpoints and evaluation criteria to measure the success of improvement initiatives
